Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 1.34 is 85% below its 5-year average of 8.85, near the low end of its 5-year range (1.34–16.99).
As of the fiscal period ended Tuesday, June 30, 2026. 61.68% below its 12-month average of 3.49.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.34.
QUICK RATIO (ACID-TEST)
1.34
QUICK RATIO (ACID-TEST) AVG TTM
3.49
QUICK RATIO (ACID-TEST) AVG 3Y
5.96
QUICK RATIO (ACID-TEST) AVG 5Y
8.85
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-61.68%
CURRENT VS 3Y AVG
-77.55%
CURRENT VS 5Y AVG
-84.89%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 870 covered companies
CURRENT VS SECTOR MEDIAN
-60.15%
vs the sector median at left
Pyxis Oncology, Inc.
Market Cap
$127.98M
Quick Ratio (Acid-Test)
1.34
TTM Avg
3.49
3Y Avg
5.96
5Y Avg
8.85
Market Cap
$127.29M
Quick Ratio (Acid-Test)
0.86
TTM Avg
0.23
3Y Avg
0.62
5Y Avg
0.88
Market Cap
$130.79M
Quick Ratio (Acid-Test)
2.70
TTM Avg
1.66
3Y Avg
3.23
5Y Avg
3.69
Market Cap
$131.21M
Quick Ratio (Acid-Test)
0.79
TTM Avg
0.57
3Y Avg
0.67
5Y Avg
0.95
Market Cap
$124.70M
Quick Ratio (Acid-Test)
8.98
TTM Avg
5.43
3Y Avg
7.69
5Y Avg
7.29
Market Cap
$124.18M
Quick Ratio (Acid-Test)
0.18
TTM Avg
2.21
3Y Avg
2.68
5Y Avg
2.62
Market Cap
$122.66M
Quick Ratio (Acid-Test)
6.61
TTM Avg
6.63
3Y Avg
5.56
5Y Avg
6.65
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pyxis Oncology, Inc. (PYXS) | $127.98M | 1.34 | 3.49 | 5.96 | 8.85 |
| NRx Pharmaceuticals, Inc. (NRXP)vs › | $127.29M | 0.86 | 0.23 | 0.62 | 0.88 |
| Health Catalyst, Inc. (HCAT)vs › | $130.79M | 2.70 | 1.66 | 3.23 | 3.69 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $131.21M | 0.79 | 0.57 | 0.67 | 0.95 |
| Entera Bio Ltd. (ENTX)vs › | $124.70M | 8.98 | 5.43 | 7.69 | 7.29 |
| TuHURA Biosciences, Inc. (HURA)vs › | $124.18M | 0.18 | 2.21 | 2.68 | 2.62 |
| LifeMD, Inc. (LFMD)vs › | $132.03M | 0.84 | 0.97 | 0.83 | 1.00 |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 6.61 | 6.63 | 5.56 | 6.65 |
| Freenome, Inc. (FRNM)vs › | $133.45M | N/A | N/A | N/A | N/A |
| BGM Group Ltd. (BGM)vs › | $122.43M | 0.65 | 1.74 | 2.55 | 2.19 |
Quick Ratio
1.34
Excludes inventory
Current Ratio
1.34
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 1.34 |
| 2026-03-31 | 2.76 |
| 2025-12-31 | 3.41 |
| 2025-09-30 | 4.29 |
| 2025-06-30 | 5.65 |
| 2025-03-31 | 7.75 |
| 2024-12-31 | 7.49 |
| 2024-09-30 | 7.33 |
| 2024-06-30 | 9.53 |
| 2024-03-31 | 12.19 |
| 2023-12-31 | 4.84 |
| 2023-09-30 | 4.91 |
| 2023-06-30 | 16.18 |
| 2023-03-31 | 13.46 |
| 2022-12-31 | 5.90 |
| 2022-09-30 | 10.62 |
| 2022-06-30 | 15.19 |
| 2022-03-31 | 13.10 |
| 2021-12-31 | 14.90 |
| 2021-09-30 | 7.98 |
| 2021-06-30 | 16.99 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 2.20 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
